ONTHERIX INC has a total of 15 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CHENGDU KANGHONG BIOLOG TECHNOLOGY CO LTD, PIERIS AG and PROTHERA BIOLOGICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Computer technology | |
#5 | Measurement | |
#6 | Micro-structure and nano-technology | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Bioinformatics | |
#6 | Analysing materials | |
#7 | Climate change adaptation technologies | |
#8 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Mascarenhas Desmond | 15 |
Publication | Filing date | Title |
---|---|---|
WO2014142933A1 | Neuroimmunological response to stress | |
US2011202281A1 | Adaptive biochemical signatures | |
EP2265272A1 | Adaptive biochemical signatures | |
US2009053203A1 | Metal-binding therapeutic peptides | |
EP2125875A2 | Metal-binding therapeutic peptides | |
US2008124346A1 | Metal-binding therapeutic peptides | |
AU2006311538A1 | Metal-binding therapeutic peptides |